~~<i id='9EAD53DB5F'><strike id='9EAD53DB5F'><tt id='9EAD53DB5F'><pre id='9EAD53DB5F'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

knowledge

author：comprehensive 2025-09-05 11:31:05 - browse：2

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

LONDON — Novo Nordisk said Monday it would acquire the German firm Cardior Pharmaceuticals in a deal worth up to $1.1 billion, picking up additional drug candidates for its pipeline of cardiometabolic medicines.

Cardior focuses on targeting RNA to address the root causes of heart disease. Its lead candidate, known CDR132L, is in Phase 2 development as a treatment for health failure.

The companies did not disclose how much Novo was paying upfront for Cardior and how much would be based on future milestones being achieved. The deal is expected to close in the second quarter.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： The painfully weak evidence on taking collagen to treat arthritis

focus

knowledge

leisure time

entertainment

Wikipedia

StephanieKeith/GettyImagesDocumentsreleasedthisweekshednewlightonanaggressivestrategyfromvapemakerJu

WSS

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Cognito secures funding to test medical device for Alzheimer's

Covid misinformation case heads to Supreme Court

SAMSHA loosens regulations on methadone treatment centers

Woodcock on FDA’s accelerated approval and her next chapter

focus

knowledge

focus

How to save PrEP access — and even expand it

Even great ERs can’t make up for American health disparities

George Santos makes 1st court appearance after pleading not guilty to 13 counts

In venture capital firm's success, lessons for turning crisis into profit

After affirmative action ruling, medical educators look to 'holistic review'

Ohioans vote in high

Psychedelics group wrestles with new pharma identity

Zapping the brain for stroke rehab: Pivotal clinical trial begins

How to save PrEP access — and even expand it

A $475,000 price tag for a new cancer drug: crazy or meh?

knowledge

Zapping the brain for stroke rehab: Pivotal clinical trial begins

Mega Millions jackpot estimated at record $1.58 billion for Tuesday's drawing

Congressmen charge Covid hearing ‘could have been an email’

Woodcock on FDA’s accelerated approval and her next chapter

Germany receives 178 compensation applications from gay servicepeople over discrimination

More regulation could be coming for drug ads

knowledge

leisure time

entertainment

Wikipedia